Zobrazeno 1 - 10
of 136
pro vyhledávání: '"H. Evin Gulbahce"'
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 2, Pp 660-665 (2017)
Primary pleuropulmonary synovial sarcomas are quite rare, representing 0.1–0.5% of all pulmonary malignancies. We report an entirely cystic monophasic synovial sarcoma in a 25-year-old male who presented with recurrent pneumothorax and no evidence
Externí odkaz:
https://doaj.org/article/0a66508e493648b0a674fbf1ea52eb2d
Publikováno v:
Human Pathology. 126:129-135
Genetic heterogeneity (GH) is a rare but important event in the evaluation of HER2 amplification status. We investigated whether HER2 fluorescence in situ hybridization (FISH) GH correlated with increased protein expression by immunohistochemistry (I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dd37965e7dc5e318fc29b5e9114e302
https://doi.org/10.1016/j.humpath.2022.05.011
https://doi.org/10.1016/j.humpath.2022.05.011
Autor:
Nicola J. Camp, Greg Stoddard, Saundra S. Buys, Sandra White, Kimberly Herget, H. Evin Gulbahce, Carol Sweeney
Publikováno v:
Journal of Geriatric Oncology. 12:206-211
Objectives The influence of older age at diagnosis in combination with race/ethnicity on utilization and results of the 21-gene recurrence score (RS) assay for breast cancer (BC) patients is not fully understood. Our objectives were to evaluate the u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc7d52b37cd42618d6712d60d75c83d6
https://doi.org/10.1016/j.jgo.2020.06.004
https://doi.org/10.1016/j.jgo.2020.06.004
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Archives of pathologylaboratory medicine. 146(4)
Context.— Recurrence score (RS) testing was developed and validated in invasive ductal and rare lobular carcinomas, although it is used for all special types of breast cancers. Objective.— To determine association of histologic type (HT) and RS,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::127a1fc6e4d6f4dd01ecab8ea1ea2bd9
https://pubmed.ncbi.nlm.nih.gov/34343231
https://pubmed.ncbi.nlm.nih.gov/34343231
Publikováno v:
Applied immunohistochemistrymolecular morphology : AIMM. 29(4)
The new ASCO/CAP guidelines on hormone receptor testing in breast cancer recommends standard operating procedures (SOPs) established to confirm or adjudicate estrogen receptor (ER) results with weak or ≤10% staining, and the status of internal cont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fc8bf242e178314e44fe1767584701f
https://pubmed.ncbi.nlm.nih.gov/33306617
https://pubmed.ncbi.nlm.nih.gov/33306617
Autor:
Lawrence H. Kushi, Erin Weltzien, Carol Sweeney, Rachel E. Factor, H. Evin Gulbahce, Bette J. Caan, Philip S. Bernard
Publikováno v:
Cancer. 124:4676-4684
BACKGROUND Although the proportion of triple-negative breast cancers (TNBCs) diagnosed among older women is low, the number of TNBC cases is substantial because of the high incidence of breast cancer after the age of 65 years. The molecular features
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74ba010eb17321befde0199272226602
https://doi.org/10.1002/cncr.31776
https://doi.org/10.1002/cncr.31776
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 2, Pp 660-665 (2017)
Case Reports in Oncology
Case Reports in Oncology
Primary pleuropulmonary synovial sarcomas are quite rare, representing 0.1–0.5% of all pulmonary malignancies. We report an entirely cystic monophasic synovial sarcoma in a 25-year-old male who presented with recurrent pneumothorax and no evidence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7c866c1ad9ced5abf62a93af0132e19
http://www.karger.com/Article/FullText/478845
http://www.karger.com/Article/FullText/478845
Publikováno v:
American journal of clinical pathology. 152(4)
ObjectivesTo review impact of the ASCO/CAP 2018 update on HER2 testing.MethodsHER2 fluorescence in situ hybridization (FISH) test requests from primary and metastatic breast cancers between August 2018 and January 2019 were included. FISH results req
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fa06b3507bd26d8eefc832468ee9df0
https://pubmed.ncbi.nlm.nih.gov/31172196
https://pubmed.ncbi.nlm.nih.gov/31172196
Autor:
Theresa L. Werner, Carlynn Willmore-Payne, H. Evin Gulbahce, Kristy Damjanovich-Colmenares, Alexandra V. Pasi, Erinn Downs-Kelly, Katherine B. Geiersbach
Publikováno v:
American Journal of Clinical Pathology. 146:618-626
Objectives: Guidelines suggest that secondary reflex testing may be useful for resolving HER2 status in breast cancers with equivocal results by both immunohistochemistry (IHC) and in situ hybridization (ISH). We compared two reflex ISH assays and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::039f2af2c82ef036200eb48b3ba4563b
https://doi.org/10.1093/ajcp/aqw177
https://doi.org/10.1093/ajcp/aqw177